Form 8-K - Current report:
SEC Accession No. 0001564590-19-007678
Filing Date
2019-03-14
Accepted
2019-03-14 08:52:46
Documents
3
Period of Report
2019-03-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K MYPATH PRESS RELEASE mygn-8k_20190314.htm 8-K 30433
2 EX-99.1 mygn-ex991_6.htm EX-99.1 20819
3 GRAPHIC gmrknciv14k1000001.jpg GRAPHIC 4299
  Complete submission text file 0001564590-19-007678.txt   58407
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 19679844
SIC: 2835 In Vitro & In Vivo Diagnostic Substances